TRPV4 channel inhibits TGF-β1-induced proliferation of hepatic stellate cells

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Songa, Yang ^a   Zhan, Lei ^a   Yu, Mingzhe ^a   Huang, Cheng ^a   Meng, Xiaoming ^a   Taotao, Ma ^a   Zhang, Lei ^a   Li, Jun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; COLLAGEN TYPE 1 ALPHA 1; MICRORNA; MICRORNA 203; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 4; CARBON TETRACHLORIDE; TRPV4 PROTEIN, HUMAN; VANILLOID RECEPTOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER FIBROSIS; MALE; MYOFIBROBLAST; NONHUMAN; PREDICTION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STELLATE CELL; TRPV4 GENE; UPREGULATION; WESTERN BLOTTING; ANIMAL; CELL LINE; CYTOLOGY; DRUG EFFECTS; GENETICS; LIVER; LIVER CIRRHOSIS; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TOXICITY;

ANIMALS; CARBON TETRACHLORIDE; CELL LINE; CELL PROLIFERATION; HEPATIC STELLATE CELLS; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; RATS; RATS, SPRAGUE-DAWLEY; TRANSFORMING GROWTH FACTOR BETA1; TRPV CATION CHANNELS;

EID: 84904258110     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101179     Document Type: Article

References (31)

1. Hernandez-Gea V, Friedman SL (2011) Pathogenesis of liver fibrosis. Annu Rev Pathol 6: 425-456.
2. Friedman SL (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology 134: 1655-1669.
3. Lee UE, Friedman SL (2011) Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol 25: 195-206.
4. Fang L, Zhan S, Huang C, Cheng X, Lv X, et al. (2013) TRPM7 channel regulates PDGF-BB-induced proliferation of hepatic stellate cells via PI3K and ERK pathways. Toxicol Appl Pharmacol 272: 713-725.
5. Liu H, Li J, Huang Y, Huang C (2012) Inhibition of transient receptor potential melastain 7 channel increases HSCs apoptosis induced by TRAIL. Life Sci 90: 612-618.
6. Nilius B (2007) TRP channels in disease. Biochim Biophys Acta 1772: 805-812.
7. Chun JN, Lim JM, Kang Y, Kim EH, Shin YC, et al. (2013) A network perspective on unraveling the role of TRP channels in biology and disease. Pflugers Arch.
8. Patel A, Sharif-Naeini R, Folgering JR, Bichet D, Duprat F, et al. (2010) Canonical TRP channels and mechanotransduction: from physiology to disease states. Pflugers Arch 460: 571-581.
9. Clark K, Middelbeek J, van Leeuwen FN (2008) Interplay between TRP channels and the cytoskeleton in health and disease. Eur J Cell Biol 87: 631-640.
10. Jordt SE, Ehrlich BE (2007) TRP channels in disease. Subcell Biochem 45: 253-271.
11. Lafyatis R (2006) Targeting fibrosis in systemic sclerosis. Endocr Metab Immune Disord Drug Targets 6: 395-400.
12. Friedman SL (1993) Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 328: 1828-1835.
13. Friedman SL (2008) Hepatic fibrosis - overview. Toxicology 254: 120-129.
14. Troeger JS, Mederacke I, Gwak GY, Dapito DH, Mu X, et al. (2012) Deactivation of hepatic stellate cells during liver fibrosis resolution in mice. Gastroenterology 143: 1073-1083 e1022.
15. Jiao J, Friedman SL, Aloman C (2009) Hepatic fibrosis. Curr Opin Gastroenterol 25: 223-229.
16. Watanabe H, Vriens J, Prenen J, Droogmans G, Voets T, et al. (2003) Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature 424: 434-438. (Pubitemid 36917492)
17. Everaerts W, Nilius B, Owsianik G (2010) The vanilloid transient receptor potential channel TRPV4: from structure to disease. Prog Biophys Mol Biol 103: 2-17.
18. Fiorio Pla A, Ong HL, Cheng KT, Brossa A, Bussolati B, et al. (2012) TRPV4 mediates tumor-derived endothelial cell migration via arachidonic acid-activated actin remodeling. Oncogene 31: 200-212.
19. Troidl C, Troidl K, Schierling W, Cai WJ, Nef H, et al. (2009) Trpv4 induces collateral vessel growth during regeneration of the arterial circulation. J Cell Mol Med 13: 2613-2621.
20. Hatano N, Suzuki H, Itoh Y, Muraki K (2013) TRPV4 partially participates in proliferation of human brain capillary endothelial cells. Life Sci 92: 317-324.
21. Zaninetti R, Fornarelli A, Ciarletta M, Lim D, Caldarelli A, et al. (2011) Activation of TRPV4 channels reduces migration of immortalized neuroendocrine cells. J Neurochem 116: 606-615.
22. Adapala RK, Thoppil RJ, Luther DJ, Paruchuri S, Meszaros JG, et al. (2013) TRPV4 channels mediate cardiac fibroblast differentiation by integrating mechanical and soluble signals. J Mol Cell Cardiol 54: 45-52.
23. Thodeti CK, Paruchuri S, Meszaros JG (2013) A TRP to cardiac fibroblast differentiation. Channels (Austin) 7: 211-214.
24. Arniges M, Vazquez E, Fernandez-Fernandez JM, Valverde MA (2004) Swelling-activated Ca2 + entry via TRPV4 channel is defective in cystic fibrosis airway epithelia. J Biol Chem 279: 54062-54068. (Pubitemid 40053140)
25. Ambros V (2001) microRNAs: tiny regulators with great potential. Cell 107: 823-826.
26. Sun X, He Y, Huang C, Ma TT, Li J (2013) The epigenetic feedback loop between DNA methylation and microRNAs in fibrotic disease with an emphasis on DNA methyltransferases. Cell Signal 25: 1870-1876.
27. He Y, Huang C, Sun X, Long XR, Lv XW, et al. (2012) MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4. Cell Signal 24: 1923-1930.
28. He Y, Huang C, Zhang SP, Sun X, Long XR, et al. (2012) The potential of microRNAs in liver fibrosis. Cell Signal 24: 2268-2272.
29. Pogribny IP, Starlard-Davenport A, Tryndyak VP, Han T, Ross SA, et al. (2010) Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice. Lab Invest 90: 1437-1446.
30. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, et al. (2010) miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 31: 766-776.
31. Hu F, Zhu W, Wang L (2012) MicroRNA-203 up-regulates nitric oxide expression in temporomandibular joint chondrocytes via targeting TRPV4. Arch Oral Biol.